View                 Download                 XML
Title : CHEMOTHERAPY UTILIZATION OF BREST CANCER IN CANCER CENTER, THAILAND
Authors : Chaninun Ketkaew, Kitisuk Thepsuwan, Niyada Kiatying-Angsule
Abstract : This study aimed to describe chemotherapy utilization situation of breast cancer patients after NHSO cancer protocol version 2010 had been launched. The 3,485 chemotherapy prescriptions of out-patient departments between January to June 2010 were analyzed. The most common prescribed chemotherapy regimens were Fluorouracil+Doxorubicin+Cyclophosphamide or FAC regimen (36.15%, 1,260 prescriptions), Cyclophosphamide+Methotrexate+Fluorouracil or CMF regimen (16.15%, 563 prescriptions), Doxorubicin+Cyclophosphamide or AC regimen (14.84%, 517 prescription), Paclitaxel (12.63%, 440 prescriptions), Capecitabine (7.49% 261 prescriptions) and Docetaxel (4.88%, 170 prescriptions). Each cancer center was significantly different in the utilization pattern due to the incidence of cancer type, hospital formularies and hospital policy (p = 0.00). 92.14% of all chemotherapy prescriptions adhered to NHSO cancer protocol. The highest ratio of adherence to cancer protocol was UC scheme (96.45%) and the lowest one was CSMBS scheme (75.50%). Each health benefit scheme was significantly different in ratio of adherence to protocol (p = 0.00). The total cost of chemotherapy regimen was 20,677,599 Baht. 16,704,514 Baht (80.79%) was the cost of adherence to protocol prescriptions.

A PHP Error was encountered

Severity: Notice

Message: Undefined index: HTTP_REFERER

Filename: views/issue_title.php

Line Number: 65

Backtrace:

File: /var/www/html/pharmascholars-com/app_psl/views/issue_title.php
Line: 65
Function: _error_handler

File: /var/www/html/pharmascholars-com/app_psl/controllers/PSL.php
Line: 144
Function: view

File: /var/www/html/pharmascholars-com/index.php
Line: 293
Function: require_once

">Back